Related Experiment Video
Updated: Mar 25, 2026
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor
Angela Lanciotti1, Maria Stefania Brignone1, Sergio Visentin1
1Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.
Abstract:
Mutations in the MLC1 gene, which encodes a protein expressed in brain astrocytes, are the leading cause of MLC, a rare leukodystrophy characterized by macrocephaly, brain edema, subcortical cysts, myelin and astrocyte vacuolation. Although recent studies indicate that MLC1 protein is implicated in the regulation of cell volume changes, the exact role of MLC1 in brain physiology and in the pathogenesis of MLC disease remains to be clarified. In preliminary experiments, we observed that MLC1 was poorly expressed in highly proliferating astrocytoma cells when compared with primary astrocytes, and that modulation of MLC1 expression influenced astrocyte growth. Because volume changes are key events in cell proliferation and during brain development MLC1 expression is inversely correlated to astrocyte progenitor proliferation levels, we investigated the possible role for MLC1 in the control of astrocyte proliferation. We found that overexpression of wild type but not mutant MLC1 in human astrocytoma cells hampered cell growth by favoring epidermal growth factor receptor (EGFR) degradation and by inhibiting EGF-induced Ca(+) entry, ERK1/2 and PLCγ1 activation, and calcium-activated KCa3.1 potassium channel function, all molecular pathways involved in astrocyte proliferation stimulation. Interestingly, MLC1 did not influence AKT, an EGFR-stimulated kinase involved in cell survival. Moreover, EGFR expression was higher in macrophages derived from MLC patients than from healthy individuals. Since reactive astrocytes proliferate and re-express EGFR in response to different pathological stimuli, the present findings provide new information on MLC pathogenesis and unravel an important role for MLC1 in other brain pathological conditions where astrocyte activation occurs.
Insights
Mutations in the MLC1 gene cause a rare leukodystrophy. This study reveals MLC1 protein controls astrocyte proliferation by inhibiting key growth pathways, offering insights into leukodystrophy and brain pathology.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mutations in the MLC1 gene cause Macrocephaly-Capillary Malformation (MLC), a rare leukodystrophy.
- The precise function of MLC1 protein in brain physiology and MLC pathogenesis is not fully understood.
- MLC1 protein is expressed in brain astrocytes and implicated in cell volume regulation.
Purpose of the Study:
- To investigate the role of MLC1 in controlling astrocyte proliferation.
- To explore the molecular mechanisms by which MLC1 influences astrocyte growth.
- To determine if MLC1 plays a role in other brain pathological conditions involving astrocyte activation.
Main Methods:
- Overexpression of wild-type and mutant MLC1 in human astrocytoma cells.
- Assessment of cell growth and proliferation rates.
- Analysis of epidermal growth factor receptor (EGFR) degradation.
- Measurement of EGF-induced calcium (Ca+) entry, ERK1/2 and PLCγ1 activation.
- Evaluation of calcium-activated KCa3.1 potassium channel function.
- Investigation of AKT signaling pathway.
- Comparison of EGFR expression in macrophages from MLC patients and healthy individuals.
Main Results:
- Overexpression of wild-type MLC1, but not mutant MLC1, inhibited astrocytoma cell growth.
- MLC1 overexpression promoted EGFR degradation and inhibited EGF-induced Ca+ entry, ERK1/2 and PLCγ1 activation.
- MLC1 inhibited calcium-activated KCa3.1 potassium channel function.
- MLC1 did not affect the AKT signaling pathway.
- EGFR expression was elevated in macrophages from MLC patients compared to controls.
Conclusions:
- MLC1 plays a crucial role in controlling astrocyte proliferation by negatively regulating key signaling pathways involved in cell growth stimulation.
- The findings provide new insights into the pathogenesis of MLC and suggest a potential role for MLC1 in other brain disorders characterized by reactive astrocyte proliferation.
More Related Videos
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
